中低收入国家咖啡因治疗早产儿呼吸暂停的障碍与促进因素调查

数据集获取（Figshare）

• 源站标题：A survey of barriers and facilitators to caffeine use for apnoea of prematurity in low- and middle-income countries
• DOI：10.6084/m9.figshare.23703143.v1
• 发布日期：2023-07-18
• 文件数：2 个
• 文件总体积：1.06 MB
• 源站页面：https://tandf.figshare.com/articles/dataset/A_survey_of_barriers_and_facilitators_to_caffeine_use_for_apnoea_of_prematurity_in_low-_and_middle-income_countries/23703143

命令行下载

curl -L -o "Caffeine Survey Supp Figure1 4May2023.jpg" "https://ndownloader.figshare.com/files/41600342"
curl -L -o "PCH3784 Supplementary Tables.docx" "https://ndownloader.figshare.com/files/41600345"

文件清单

• Caffeine Survey Supp Figure1 4May2023.jpg（1.03 MB）
• PCH3784 Supplementary Tables.docx（23.36 KB）

文件总体积 1.06 MB（源站 API 实测）。

数据说明

Despite its associated benefits which include better long-term pulmonary and neurodevelopmental outcome, the use of caffeine for apnoea of prematurity (AoP) has been limited in low- and middle-income countries (LMIC).
To better understand current caffeine use, the barriers and facilitators to its use and perceptions and practices in LMIC which have a disproportionately high burden of prematurity.
An anonymous online global survey was conducted, targeting healthcare providers working and training in paediatrics and/or neonatology in LMIC.
A total of 181 respondents in 16 LMIC were included in the analysis; most were physicians working in publicly-funded urban tertiary hospitals. Most had received training in the use of caffeine for AoP (77%), reported expertise (70%) and confidence (96%) in its use, and had access to caffeine (65%). Caffeine availability was reported to be the greatest barrier (48%) and the greatest facilitator (37%). Other common barriers included cost (31%), access (7%) and policies or guidelines on caffeine use (7%); other common facilitators included policies or guidelines on caffeine use (11%), access (10%), staff/other providers’ acceptance of caffeine as an appropriate treatment (9%) and the availability of staff to administer caffeine (8%). Most (79%) noted that access to caffeine was important, 92% agreed that caffeine improves quality of care, and 95% agreed that caffeine improves patient outcome.
Improving availability and access to low-cost caffeine will be key to increasing caffeine use in LMIC.
AoP: Apnoea of Prematurity; LMIC: low- and middle-Income countries; REDCap: Research Electronic Data Capture.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.23703143.v1（source: https://tandf.figshare.com/articles/dataset/A_survey_of_barriers_and_facilitators_to_caffeine_use_for_apnoea_of_prematurity_in_low-_and_middle-income_countries/23703143）。